BeStock  

Adaptive Biotechnologies ADPT

US equityMarket cap rank #2124Diagnostics & Research
$27.93 −$0.12 (-0.43%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.89 -0.14%
Open$27.43
Prev close$28.05
Day range$27.15 – $28.23
Volume2.48M
Market cap$4.52B
P/E (TTM)–
Dividend yield–

ADPT Stock News

Headlines matching Adaptive Biotechnologies or the ADPT ticker, most recent first.

  • Goldman Sachs Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $35Market news · 29 Sep 2026 · Direct mention
  • BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $34Market news · 22 Sep 2026 · Direct mention
  • BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $34 PositiveMarket news · 22 Sep 2026 · Direct mention
  • Adaptive Biotechnologies(ADPT.US) Officer Sells US$3.24 Million in Common StockMarket news · 19 Sep 2026 · Direct mention
  • Craig-Hallum Maintains Adaptive Biotechnologies(ADPT.US) With Buy RatingMarket news · 18 Sep 2026 · Direct mention
  • Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $27.5 PositiveMarket news · 4 Aug 2026 · Direct mention
  • Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $27.5Market news · 24 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $25 to $28Market news · 31 Jul 2026 · Direct mention
  • BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $24 PositiveMarket news · 23 Jul 2026 · Direct mention
  • TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $25 PositiveMarket news · 15 Jul 2026 · Direct mention
  • Guggenheim Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $22 PositiveMarket news · 29 Jun 2026 · Direct mention
  • William Blair Maintains Adaptive Biotechnologies(ADPT.US) With Buy RatingMarket news · 17 Jun 2026 · Direct mention
  • A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $19 to $22Market news · 6 May 2026 · Direct mention
  • Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Cuts Target Price to $13.54 NegativeMarket news · 12 May 2026 · Direct mention
  • Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $20Market news · 12 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ADPT.

Sign in to join the discussion.

Scroll to Top